Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Documents Breakthrough COVID-19 Infections in Vaccinated Healthcare Workers

Lara C. Pullen, PhD  |  March 7, 2022

In December 2020, University of California, San Diego (UCSD) Health began vaccinating healthcare workers against the severe acute respiratory syndrome caused by SARS-CoV-2 (COVID-19) with mRNA vaccines: BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna). Even after the vaccine rollout, UCSD Health continued its daily screening of all workers for COVID-19 symptoms or exposure. Those who were positive during the screening were tested for COVID-19 infection.

Jocelyn Keehner, MD, a third-year infectious disease fellow at UCSD Health, and colleagues used the vaccination and testing data collected during this process to calculate vaccine effectiveness for every month from March 2021 to July 2021. The investigators documented a dramatic change in vaccine effectiveness from June 2021 (94.3%) to July 2021(65.5%). They believe this decrease resulted from both the emergence of the delta variant and the waning immunity from the vaccination. Their findings were published on Sept. 30, 2021, in the New England Journal of Medicine.1 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The San Diego Experience

Prior to the availability of a vaccine, healthcare workers at UCSD Health experienced a dramatic increase in SARS-CoV-2 infections. However, the number of positive tests decreased as the workforce became vaccinated. At the end of March 2021, UCSD Health had vaccinated 76% of its workforce. By the end of June 2021, 87% of the workforce was vaccinated, and by the end of July 2021, close to 99% of the workforce was fully vaccinated.

According to senior author Francesca J. Torriani, MD, an infectious disease specialist at UCSD Health, the study was prompted by the fact that in June 2021 UCSD Health began documenting breakthrough COVID-19 infections. Up until that time, these cases had been rare.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The spring and early summer of 2021 also saw two notable changes in the pandemic in San Diego: In April 2021, UCSD Health documented its first cases of the delta variant in healthcare workers. In June 2021, California decreased its pandemic restriction and community mask use decreased. Thus, the area experienced an increase in infections in the spring, and the delta strain became the dominant strain in the area.

Waning Protection Strains Health System

Of the 227 UCSD Health infections that occurred from March 1 to July 31, Dr. Torriani’s team found that 130 (57.3%) occurred in individuals who were fully vaccinated. They questioned whether the infection in vaccinated workers was due to increased viral load from the delta variant or waning immunity from the vaccines.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsProfessional Topics Tagged with:COVID-19health professionalshealthcare workersvaccines

Related Articles

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    June 13, 2021

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences